Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00072358
First received: November 4, 2003
Last updated: October 9, 2015
Last verified: October 2015